BACKGROUND: The Antenatal Corticosteroid Trial (ACT) assessed the feasibility, effectiveness, and safety of a multifaceted intervention to increase the use of antenatal corticosteroids (ACS) in mothers at risk of preterm birth at all levels of care in low and middle-income countries. The intervention effectively increased the use of ACS but had no overall impact on neonatal mortality in the targeted
The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial
Klein, K., McClure, E., Colaci, D., Thorsten, V., Hibberd, PL., Esamai, F., Garces, A., Patel, A., Saleem, S., Pasha, O., Chomba, E., Carlo, WA., Krebs, NF., Goudar, S., Derman, RJ., Liechty, EA., Koso-Thomas, M., Buekens, PM., Belizan, JM., ... Althabe, F. (2016). The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial. Reproductive Health, 13, e64. [64]. https://doi.org/10.1186/s12978-016-0179-z
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Meet the Experts
View All ExpertsRecent Publications
Article
The daily association between affect and alcohol use: A meta-analysis of individual participant data
Article
Protection of forest ecosystems in the eastern United States from elevated atmospheric deposition of sulfur and nitrogen
Article
The use of patient experience feedback in rehabilitation quality improvement and codesign activities
Article